NATCO Pharma Limited (NATCOPHARM)
₹1,366.75
INR-19.50(-1.41%)
As of January 3, 2025 10:00:00 AMValuation Metrics
Market Cap
Total market value of the company's outstanding shares
₹25378.99 Cr
Enterprise Value
Total value of the company including debt and excluding cash
₹23134.08 Cr
P/E Ratio (TTM)
Price to Earnings ratio based on trailing 12 months
13.05
Forward P/E
Price to Earnings ratio based on forecasted earnings
34.33
PEG Ratio
Price/Earnings to Growth ratio
34.33
Price to Sales (TTM)
Price to Sales ratio based on trailing 12 months
5.56
Financial Metrics
Gross Margin
Gross profit as a percentage of revenue
87.05%
Operating Margin
Operating income as a percentage of revenue
55.32%
Return on Equity
Net income as a percentage of shareholders' equity
31.23%
Revenue (TTM)
Total revenue over trailing 12 months
₹4563.80 Cr+32.9%
EBITDA
Earnings Before Interest, Taxes, Depreciation, and Amortization
₹2558.20 Cr
EPS (TTM)
Earnings Per Share over trailing 12 months
₹108.54+83.6%
Balance Sheet
Total Cash
Total cash and short-term investments
₹2463.40 Cr
Total Debt
Total short-term and long-term debt
₹208.40 Cr
Debt to Equity
Total debt as a percentage of shareholders' equity
2.91%
Stock Information
52 Week Range
Lowest and highest stock price over the past 52 weeks
₹805 - ₹1639
Beta
Measure of stock's volatility compared to the market
0.52
Shares Outstanding
Total number of shares issued by the company
₹17.91 Cr
Dividends & Splits
Forward Dividend Yield
Expected dividend yield based on forward dividend rate
0.49%
Trailing Dividend Yield
Dividend yield based on trailing 12 months
0.08%
Payout Ratio
Percentage of earnings paid as dividends
5.06%